lipoxin a4 and Pancreatitis

lipoxin a4 has been researched along with Pancreatitis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Chen, Z; Tong, K; Wang, M; Wen, Z1
Chen, B; Ni, X; Pan, R; Shi, K; Shi, Z; Sun, H; Xiang, Y; Ye, W; Yu, D; Zhang, F; Zhang, Q; Zhang, Z; Zheng, C; Zhou, M1
Chen, B; Shi, Z; Sun, H; Ye, W; Yu, D; Yu, H; Zhang, F; Zhang, J; Zhou, M1
Andersson, R; Chen, B; Kong, H; Lv, C; Lv, W; Sun, H; Xie, J; Xu, D; Yang, Y; Yu, S; Zhou, M1
Bao, JJ; Ding, H; Hu, C; Liu, XC; Mei, Q; Xu, JM; Zhao, XW1
Andersson, R; Chen, B; Jin, Y; Sun, H; Wang, W; Xie, J; Xie, Y; Xu, D; Yang, F; Zhou, M1
Abbasinazari, M; Abdi, S; Ahmadpour, F; Dabir, S; Fatehi, S; Hatami, B; Mohammad Alizadeh, AH; Nematollahi, A; Pourhoseingholi, MA1
Andersson, R; Chen, B; Deng, Z; Sun, H; Zhang, Q; Zhou, M1
Fang, HM; Hu, CY; Hu, DM; Li, LY; Qian, MJ; Wang, SF; Yang, Y; Zhou, CH; Zhu, XY1

Trials

2 trial(s) available for lipoxin a4 and Pancreatitis

ArticleYear
Effect of diclofenac on the levels of lipoxin A4 and Resolvin D1 and E1 in the post-ERCP pancreatitis.
    Digestive diseases and sciences, 2014, Volume: 59, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopic Retrograde; Diclofenac; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Lipoxins; Pancreatitis

2014
Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:3

    Topics: Administration, Rectal; Adult; Aged; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cholangiopancreatography, Endoscopic Retrograde; Diclofenac; Double-Blind Method; Eicosapentaenoic Acid; Female; Humans; Incidence; Indomethacin; Iran; Lipase; Lipoxins; Male; Middle Aged; Naproxen; Pancreatitis; Risk Factors; Time Factors; Treatment Outcome

2017

Other Studies

7 other study(ies) available for lipoxin a4 and Pancreatitis

ArticleYear
Mechanisms of 15-Epi-LXA4-Mediated HO-1 in Cytoprotection Following Inflammatory Injury.
    The Journal of surgical research, 2023, Volume: 281

    Topics: Acute Disease; Acute Lung Injury; Cytoprotection; Endothelial Cells; Heme Oxygenase-1; Humans; Kelch-Like ECH-Associated Protein 1; NF-E2-Related Factor 2; Oxidative Stress; Pancreatitis; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Tumor Necrosis Factor-alpha

2023
Lipoxin A4 Ameliorates Acute Pancreatitis-Associated Acute Lung Injury through the Antioxidative and Anti-Inflammatory Effects of the Nrf2 Pathway.
    Oxidative medicine and cellular longevity, 2019, Volume: 2019

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Humans; Lipoxins; Mice; Mice, Knockout; NF-E2-Related Factor 2; Pancreatitis; Signal Transduction

2019
LipoxinA4 attenuates acute pancreatitis-associated acute lung injury by regulating AQP-5 and MMP-9 expression, anti-apoptosis and PKC/SSeCKS-mediated F-actin activation.
    Molecular immunology, 2018, Volume: 103

    Topics: A Kinase Anchor Proteins; Actins; Acute Disease; Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aquaporin 5; Cell Cycle Proteins; Cells, Cultured; Gene Expression; Humans; Lipoxins; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Pancreatitis; Protein Kinase C; Signal Transduction

2018
Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury.
    Experimental biology and medicine (Maywood, N.J.), 2013, Volume: 238, Issue:12

    Topics: Acute Lung Injury; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cells, Cultured; Chemokine CCL8; E-Selectin; eIF-2 Kinase; Endothelium, Vascular; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Lipoxins; Lung; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pancreatitis; Real-Time Polymerase Chain Reaction; Tumor Necrosis Factor-alpha

2013
Regional arterial infusion with lipoxin A4 attenuates experimental severe acute pancreatitis.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cytokines; Heme Oxygenase-1; Inflammation; Infusions, Intra-Arterial; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Lipoxins; Male; Pancreas; Pancreatitis; Peroxidase; Phospholipases A2; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2014
The protective effects of Lipoxin A4 during the early phase of severe acute pancreatitis in rats.
    Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:2

    Topics: Amylases; Animals; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-6; Lipoxins; Lung; Lung Injury; Male; NF-kappa B; Pancreatitis; Rats; Rats, Sprague-Dawley; Signal Transduction; Systemic Inflammatory Response Syndrome; Taurocholic Acid; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2011
[Protective effects and possible mechanism of lipoxin A(4) analogue in rats with acute pancreatitis].
    Zhonghua yi xue za zhi, 2012, Apr-10, Volume: 92, Issue:14

    Topics: Acute Disease; Animals; Intercellular Adhesion Molecule-1; Lipoxins; Male; NF-kappa B; Pancreatitis; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha

2012